Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Phase II study of first-line ¹³¹I-rituximab radioimmunotherapy in follicular non-Hodgkin lymphoma and prognostic ¹⁸F-fluorodeoxyglucose positron emission tomography.

Autor: McQuillan, Andrew D.¹ (AUTHOR), Macdonald, William B. G.² (AUTHOR), Turner, J. Harvey² (AUTHOR) Harvey.Turner@health.wa.gov.au

Publikováno v: Leukemia & Lymphoma. May2015, Vol. 56 Issue 5, p1271-1277. 7p.

First-Line Radio-Immunotherapy of Newly Diagnosed, Advanced Follicular Non-Hodgkin Lymphoma with 131I-Rituximab: The INITIAL Study,

Autor: McQuillan, Andrew D ^*, Macdonald, William BG ^*, Leahy, Michael F, Turner, J Harvey ^*

Publikováno v: In Blood 18 November 2011 118(21):3719-3719

Venous thromboembolism in travellers: can we identify those at risk?

Autor: McQuillan AD; Department of Haematology, Royal Perth Hospital, Perth, Australia, and School of Medicine and Pharmacology, University of Western Australia. Andrew.McQuillan@health.wa.gov.au, Eikelboom JW, Baker RI

Publikováno v: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2003 Oct; Vol. 14 (7), pp. 671-5.